Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

640 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.
Candotti D, Temple J, Owusu-Ofori S, Allain JP. Candotti D, et al. Among authors: temple j. J Virol Methods. 2004 Jun 1;118(1):39-47. doi: 10.1016/j.jviromet.2004.01.017. J Virol Methods. 2004. PMID: 15158067
HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus.
Power JP, El Chaar M, Temple J, Thomas M, Spillane D, Candotti D, Allain JP. Power JP, et al. Among authors: temple j. J Hepatol. 2010 Oct;53(4):780-7. doi: 10.1016/j.jhep.2010.04.034. Epub 2010 Jun 27. J Hepatol. 2010. PMID: 20638744
Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Owusu-Ofori S, et al. Among authors: temple j. Transfusion. 2005 Feb;45(2):133-40. doi: 10.1111/j.1537-2995.2004.04279.x. Transfusion. 2005. PMID: 15660820
Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.
Candotti D, Richetin A, Cant B, Temple J, Sims C, Reeves I, Barbara JA, Allain JP. Candotti D, et al. Among authors: temple j. Transfusion. 2003 Feb;43(2):215-25. doi: 10.1046/j.1537-2995.2003.00308.x. Transfusion. 2003. PMID: 12559017
Molecular characterization of occult hepatitis B virus in genotype E-infected subjects.
Zahn A, Li C, Danso K, Candotti D, Owusu-Ofori S, Temple J, Allain JP. Zahn A, et al. Among authors: temple j. J Gen Virol. 2008 Feb;89(Pt 2):409-418. doi: 10.1099/vir.0.83347-0. J Gen Virol. 2008. PMID: 18198371
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.
Schwarz RF, Ng CK, Cooke SL, Newman S, Temple J, Piskorz AM, Gale D, Sayal K, Murtaza M, Baldwin PJ, Rosenfeld N, Earl HM, Sala E, Jimenez-Linan M, Parkinson CA, Markowetz F, Brenton JD. Schwarz RF, et al. Among authors: temple j. PLoS Med. 2015 Feb 24;12(2):e1001789. doi: 10.1371/journal.pmed.1001789. eCollection 2015 Feb. PLoS Med. 2015. PMID: 25710373 Free PMC article.
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD. Ahmed AA, et al. Among authors: temple j. J Pathol. 2010 May;221(1):49-56. doi: 10.1002/path.2696. J Pathol. 2010. PMID: 20229506 Free PMC article.
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer.
Ng CK, Cooke SL, Howe K, Newman S, Xian J, Temple J, Batty EM, Pole JC, Langdon SP, Edwards PA, Brenton JD. Ng CK, et al. Among authors: temple j. J Pathol. 2012 Apr;226(5):703-12. doi: 10.1002/path.3980. Epub 2012 Feb 9. J Pathol. 2012. PMID: 22183581
640 results
Jump to page
Feedback